HU9600005D0 - Novel substituted benzimidazoles - Google Patents
Novel substituted benzimidazolesInfo
- Publication number
- HU9600005D0 HU9600005D0 HU9600005A HU9600005A HU9600005D0 HU 9600005 D0 HU9600005 D0 HU 9600005D0 HU 9600005 A HU9600005 A HU 9600005A HU 9600005 A HU9600005 A HU 9600005A HU 9600005 D0 HU9600005 D0 HU 9600005D0
- Authority
- HU
- Hungary
- Prior art keywords
- novel substituted
- substituted benzimidazoles
- benzimidazoles
- novel
- substituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9400511 | 1994-05-27 |
Publications (1)
Publication Number | Publication Date |
---|---|
HU9600005D0 true HU9600005D0 (en) | 1996-03-28 |
Family
ID=20392945
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU9600005A HU9600005D0 (en) | 1994-05-27 | 1995-05-11 | Novel substituted benzimidazoles |
Country Status (18)
Country | Link |
---|---|
EP (1) | EP0712401A1 (en) |
JP (1) | JPH09504557A (en) |
CN (1) | CN1128997A (en) |
AU (1) | AU2633095A (en) |
BR (1) | BR9506235A (en) |
CA (1) | CA2166988A1 (en) |
CZ (1) | CZ24396A3 (en) |
EE (1) | EE9600011A (en) |
FI (1) | FI960367A0 (en) |
HU (1) | HU9600005D0 (en) |
IL (1) | IL113604A0 (en) |
IS (1) | IS4321A (en) |
MA (1) | MA23563A1 (en) |
NO (1) | NO960268D0 (en) |
PL (1) | PL312692A1 (en) |
TN (1) | TNSN95062A1 (en) |
WO (1) | WO1995032959A1 (en) |
ZA (1) | ZA954125B (en) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9423970D0 (en) * | 1994-11-28 | 1995-01-11 | Astra Ab | Oxidation |
GB9423968D0 (en) * | 1994-11-28 | 1995-01-11 | Astra Ab | Resolution |
US5840737A (en) | 1996-01-04 | 1998-11-24 | The Curators Of The University Of Missouri | Omeprazole solution and method for using same |
US6489346B1 (en) | 1996-01-04 | 2002-12-03 | The Curators Of The University Of Missouri | Substituted benzimidazole dosage forms and method of using same |
BR9915421A (en) * | 1998-11-18 | 2001-08-07 | Astrazeneca Ab | Process for the manufacture of slightly soluble or less soluble alkaline salts of substituted sulfinyl heterocycles, pharmaceutical dosage form, use thereof, method of treating gastrointestinal diseases, and process for the manufacture of a pharmaceutical dosage form. |
US8206741B2 (en) | 2001-06-01 | 2012-06-26 | Pozen Inc. | Pharmaceutical compositions for the coordinated delivery of NSAIDs |
US8993599B2 (en) | 2003-07-18 | 2015-03-31 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
US8906940B2 (en) | 2004-05-25 | 2014-12-09 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
EP2486910A3 (en) | 2006-10-27 | 2012-08-22 | The Curators Of The University Of Missouri | Multi-chambered apparatus comprising a dispenser head |
US8247440B2 (en) | 2008-02-20 | 2012-08-21 | Curators Of The University Of Missouri | Composition comprising omeprazole, lansoprazole and at least one buffering agent |
BRPI0918492A2 (en) | 2008-09-09 | 2015-12-01 | Astrazeneca Ab | use of naproxen, or pharmaceutically acceptable salt thereof, and esomeprazole, or pharmaceutically acceptable salt thereof |
SG176724A1 (en) | 2009-06-25 | 2012-01-30 | Astrazeneca Ab | Method for treating a patient at risk for developing an nsaid-associated ulcer |
US9539214B2 (en) | 2011-12-28 | 2017-01-10 | Pozen Inc. | Compositions and methods for delivery of omeprazole plus acetylsalicylic acid |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3049367B2 (en) * | 1990-06-20 | 2000-06-05 | アストラゼネカ・アクチエボラーグ | Dialkoxy-pyridinyl-benzimidazole derivative, process for producing the same, and medicament containing the same |
DE4035455A1 (en) * | 1990-11-08 | 1992-05-14 | Byk Gulden Lomberg Chem Fab | ENANTIOMER SEPARATION |
-
1994
- 1994-05-29 TN TNTNSN95062A patent/TNSN95062A1/en unknown
-
1995
- 1995-05-03 IL IL11360495A patent/IL113604A0/en unknown
- 1995-05-11 WO PCT/SE1995/000519 patent/WO1995032959A1/en not_active Application Discontinuation
- 1995-05-11 CA CA002166988A patent/CA2166988A1/en not_active Abandoned
- 1995-05-11 AU AU26330/95A patent/AU2633095A/en not_active Abandoned
- 1995-05-11 PL PL95312692A patent/PL312692A1/en unknown
- 1995-05-11 JP JP8500730A patent/JPH09504557A/en active Pending
- 1995-05-11 HU HU9600005A patent/HU9600005D0/en unknown
- 1995-05-11 CZ CZ96243A patent/CZ24396A3/en unknown
- 1995-05-11 CN CN95190482A patent/CN1128997A/en active Pending
- 1995-05-11 EE EE9600011A patent/EE9600011A/en unknown
- 1995-05-11 BR BR9506235A patent/BR9506235A/en not_active Application Discontinuation
- 1995-05-11 EP EP95921187A patent/EP0712401A1/en not_active Withdrawn
- 1995-05-19 ZA ZA954125A patent/ZA954125B/en unknown
- 1995-05-26 MA MA23901A patent/MA23563A1/en unknown
-
1996
- 1996-01-17 IS IS4321A patent/IS4321A/en unknown
- 1996-01-23 NO NO960268A patent/NO960268D0/en unknown
- 1996-01-26 FI FI960367A patent/FI960367A0/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
JPH09504557A (en) | 1997-05-06 |
AU2633095A (en) | 1995-12-21 |
ZA954125B (en) | 1995-11-27 |
MA23563A1 (en) | 1995-12-31 |
FI960367A (en) | 1996-01-26 |
NO960268L (en) | 1996-01-23 |
EP0712401A1 (en) | 1996-05-22 |
TNSN95062A1 (en) | 1996-02-06 |
IS4321A (en) | 1996-01-17 |
PL312692A1 (en) | 1996-05-13 |
NO960268D0 (en) | 1996-01-23 |
BR9506235A (en) | 1997-08-12 |
FI960367A0 (en) | 1996-01-26 |
WO1995032959A1 (en) | 1995-12-07 |
EE9600011A (en) | 1996-04-15 |
CN1128997A (en) | 1996-08-14 |
CZ24396A3 (en) | 1996-06-12 |
IL113604A0 (en) | 1995-08-31 |
CA2166988A1 (en) | 1995-12-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5665737B1 (en) | Substituted benzoxazoles | |
HU9503549D0 (en) | Substituted 1h-imidazoles | |
IL123147A0 (en) | Benzimidazole compounds | |
EP0778836A4 (en) | Substituted 9-alkyladenines | |
AU1483295A (en) | Benzimidazoles | |
EP0775134A4 (en) | Novel benzimidazole derivatives | |
HU9502378D0 (en) | Substituted biphenyl-oxazolinones | |
ZA954095B (en) | Substituted 3-phenylpyrazoles | |
HU9600005D0 (en) | Novel substituted benzimidazoles | |
ZA956011B (en) | Substituted triazolylmethylphenylnaphthyridones | |
ZA954546B (en) | Substituted 3-phenylpyrazoles | |
SG73418A1 (en) | Novel dihydrodibenzoquinolinediones | |
AU122938S (en) | Breadbox | |
ZA954129B (en) | Novel substituted benzimidazoles | |
GB9405352D0 (en) | Henry | |
ZA951092B (en) | Substituted oxazacycloalkenes | |
HU9402476D0 (en) | (piperidino-alkyl)-aryl-ethers | |
ZA956706B (en) | Substituted biphenyloxazolines | |
SG33624A1 (en) | Substituted 1H-imidazoles | |
CA73835S (en) | Air-purifier | |
CA73798S (en) | Air-purifier | |
GB9416143D0 (en) | Benzimidazole derivatives | |
GB9410425D0 (en) | Novel bishydrazides | |
GB9410400D0 (en) | Novel bishydrazides | |
SG33449A1 (en) | Novel pyrrolocarbazoles |